Yayın:
The clinical spectrum of leukocyte adhesion deficiency (LAD) III due to defective CalDAG-GEF1

Placeholder

Tarih

Akademik Birimler

Kurum Yazarları

Kılıç, Sara Şebnem

Yazarlar

Etzioni, Amos

Danışman

Dil

Türü

Yayıncı:

Springer/Plenum Publishers

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Özet

Leukocyte adhesion deficiency (LAD) type III is a rare syndrome characterized by severe recurrent infections, leukocytosis, and increased bleeding tendency. All integrins are normally expressed yet a defect in their activation leads to the observed clinical manifestations. Less than 20 patients have been reported world wide and the primary genetic defect was identified in some of them. Here we describe the clinical features of patients in whom a mutation in the calcium and diacylglycerol-regulated guanine nucleotide exchange factor 1 (CalDAG GEF1) was found and compare them to other cases of LAD III and to animal models harboring a mutation in the CalDAG GEF1 gene. The hallmarks of the syndrome are recurrent infections accompanied by severe bleeding episodes distinguished by osteopetrosis like bone abnormalities and neurodevelopmental defects.

Açıklama

Kaynak:

Anahtar Kelimeler:

Konusu

Adhesion, Bleeding, Immunodeficiency, Infections, Integrins, Leukocytes, Platelets, Congenital disorders, Integrin activation, Gene-mutations, Gefi, Lymphocytes, Platelets, Beta-2, Immunology

Alıntı

Kılıç, S. Ş. ve Etzioni, A. (2009). "The clinical spectrum of leukocyte adhesion deficiency (LAD) III due to defective CalDAG-GEF1". Journal of Clinical Immunology, 29(1), 117-122.

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details